Bumper Offer - Urjas oil Just @ Rs. 1
Metapro 3D Tablet is an allopathic medicine The correct dosage of Metapro 3D Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Metapro 3D Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Metapro 3D Tablet is used -
Severe
Moderate
Mild
Common
Is the use of Metapro 3D Tablet safe for pregnant women?
Metapro 3D Tablet should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Metapro 3D Tablet safe during breastfeeding?
Side effects of Metapro 3D Tablet on breastfeeding women are very mild.
What is the effect of Metapro 3D Tablet on the Kidneys?
Metapro 3D Tablet does not damage the kidneys.
What is the effect of Metapro 3D Tablet on the Liver?
Very few cases of side effects of Metapro 3D Tablet on the liver have been reported.
What is the effect of Metapro 3D Tablet on the Heart?
Metapro 3D Tablet is rarely harmful for the heart.
Metapro 3D Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Metapro 3D Tablet unless your doctor advises you to do so -
Is this Metapro 3D Tablet habit forming or addictive?
Metapro 3D Tablet is not addictive in nature.
Interaction between Food and Metapro 3D Tablet
Taking Metapro 3D Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Metapro 3D Tablet
Consult your doctor before consuming alcohol while taking Metapro 3D Tablet as it can have severe side effects.
Metapro 3D Tablet is a brand name of chlorthalidone and it is available in the form of tablets. It belongs to the class of drugs known as thiazide diuretics. Metapro 3D Tablet is a prescription drug that is used in hypertension (high blood pressure) and reduces swelling of liver and kidney due to excess accumulation of fluid.
No, Metapro 3D Tablet should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
Take Metapro 3D Tablet as advised by your doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
Yes, Metapro 3D Tablet may cause hair loss. If you are experiencing severe hair loss after taking this drug, you are advised to consult it with your doctor.
Metapro 3D Tablet works by increasing the rate of urine formation by inhibiting the sodium and potassium reabsorption in the kidney, this causes more frequent urination than normal. The increased flow of urination leads to a decrease in blood volume that helps in the relaxation of the walls of blood vessels and this results in a decrease in blood pressure.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
